Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Development and characterization of Decitabine Niosomes
View through CrossRef
The present study was focused on formulating and evaluating Decitabine containing niosomes formulation for In Vitro studies. Niosomal formulations were prepared by using different ratio of surfactant (Tween 80 and Tween 20) and cholesterol by thin film hydration method and were evaluated for In Vitro characteristics, stability studies. Span 20 containing niosomal formulation displayed highest entrapment efficiency with desired particle size. SEM analyses showed that niosomal formulation was spherical in shape. Niosomes containing Tween 20 displayed higher percentage of drug release after 8 h as compared to other formulations. F-7 formulation was found to be stable at the end of the study on storage condition. The present study suggested that niosomal formulations provide sustained and prolonged delivery of drug with enhance bioavailability.
Title: Development and characterization of Decitabine Niosomes
Description:
The present study was focused on formulating and evaluating Decitabine containing niosomes formulation for In Vitro studies.
Niosomal formulations were prepared by using different ratio of surfactant (Tween 80 and Tween 20) and cholesterol by thin film hydration method and were evaluated for In Vitro characteristics, stability studies.
Span 20 containing niosomal formulation displayed highest entrapment efficiency with desired particle size.
SEM analyses showed that niosomal formulation was spherical in shape.
Niosomes containing Tween 20 displayed higher percentage of drug release after 8 h as compared to other formulations.
F-7 formulation was found to be stable at the end of the study on storage condition.
The present study suggested that niosomal formulations provide sustained and prolonged delivery of drug with enhance bioavailability.
Related Results
Nouvelles formulations nanoparticulaires de décitabine pour le traitement des leucémies aigues myéloïdes
Nouvelles formulations nanoparticulaires de décitabine pour le traitement des leucémies aigues myéloïdes
Ces travaux de thèse ont porté sur le développement de formulations innovantes et nanoparticulaire, destinées à améliorer la prise en charge des patients atteints de leucémie aigüe...
Preparation of Nano Niosomes Loaded with Rutin and Aloe Gel Extract
Preparation of Nano Niosomes Loaded with Rutin and Aloe Gel Extract
Rutin is a natural flavonoid that has many effects on human health and beauty. However, rutin has low solubility and bioavailability. Niosomes are drug delivery system that enhance...
Restoring hematopoiesis after low dose decitabine of poor graft function post allogenic hematopoietic stem cell transplantation
Restoring hematopoiesis after low dose decitabine of poor graft function post allogenic hematopoietic stem cell transplantation
Abstract
Introduction: Poor graft function (PGF), characterized by pancytopenia, is an intractable complication followin...
A Review Article Niosomal Drug Delivery for Oral Route
A Review Article Niosomal Drug Delivery for Oral Route
Niosomes are artificial vesicles with potential technological advantages. They are non- ionic surfactant vesicles. As efficient drug delivery systems with a wide range of uses, niosom...
Microtransplantation with Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes
Microtransplantation with Decitabine and Cytarabine Improves Patient Outcomes in Myelodysplastic Syndromes
Abstract
Abstract 1709
The outcome of myelodysplastic syndromes (MDS) still remains unsatisfactory, with a low complete remission (CR) rate and a poor...
A COMPREHENSIVE REVIEW ON NIOSOMES
A COMPREHENSIVE REVIEW ON NIOSOMES
Niosomes are a bilayered non-toxic, non-immunogenic nanoparticular delivery system; it is being used for drug delivery. Owing to its cost-effectiveness and easy manufacturing proce...
Therapeutic effect of folic acid combined with decitabine on diabetic mice
Therapeutic effect of folic acid combined with decitabine on diabetic mice
AIM: To evaluate the therapeutic effect of folic acid combined with decitabine on diabetic mice.
METHODS: The diabetic model of db/db mice were randomly divided into model group, f...
Decitabine Activity in Chronic Myelomonocytic Leukemia Patients
Decitabine Activity in Chronic Myelomonocytic Leukemia Patients
Abstract
Background: Epigenetic therapy with hypomethylating agents has recently been approved for the treatment of myelodysplastic syndromes (MDS) in Argentina. Chr...